Encapsulation of individual mammalian cells as a cell-based drug delivery carrier for lung cancer treatment
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2024.12.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Chaochen Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical 3D Printing Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, PR China; Henan Institute …. Hauptthemen laut MEDLINE: Lung Neoplasms, Antineoplastic Agents, Drug Delivery Systems, Drug Carriers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cell-based delivery holds great promise for advancing cell therapy, but it often faces challenges such as low cell survival rates and immunological rejection during cell injection and circulation. In this study, we develop an alternative approach aimed at engineering cell membranes to produce encapsulated individual mammalian (EIM) cells. The encapsulation shell was formed by catalyzing the reaction of H2O2 with hyaluronic acid-dopamine (HA-DA) on the cell surface using horseradish peroxidase (HRP) enzymes. This protective shell not only protects live mammalian cells from physical stress but also from biological assaults. The individual cell encapsulation system enables the loading of cells with chemotherapy drugs, enhancing their targeting ability towards tumor sites and resulting in over 5.1-fold cell enrichment at metastatic tumors, thereby improving tumor-killing efficacy and reducing metastasis. Overall, the individual cell encapsulation system demonstrates potential for targeted drug delivery to the lungs in the treatment of lung cancer by reducing side effects and enhancing treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical 3D Printing Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, PR China; Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou 450003, PR Chi…
- Department of Orthopedic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, PR China.
- Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou 450003, PR China.
- Medical Research Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, PR China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shi, C., Chen, T., Li, Y., Li, W., Shen, Y., Cai, K., Wang, M., & Chen, Y. (2025). Encapsulation of individual mammalian cells as a cell-based drug delivery carrier for lung cancer treatment. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.12.013
Vancouver
Shi C, Chen T, Li Y, Li W, Shen Y, Cai K, et al. Encapsulation of individual mammalian cells as a cell-based drug delivery carrier for lung cancer treatment. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2024.12.013
BibTeX
@article{Shi2025,
author = {Shi, Chaochen and Chen, Tao and Li, Yingying and Li, Wenshuai and Shen, Yuan and Cai, Kehan and Wang, Ming and Chen, Yazhou},
title = {Encapsulation of individual mammalian cells as a cell-based drug delivery carrier for lung cancer treatment},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2024.12.013}
}
EUVIMED